Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

VALIANT LABORATORIES LTD.

NSE : VALIANTLABBSE : 543998ISIN CODE : INE0JWS01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE66.43-0.67 (-1 %)
PREV CLOSE () 67.10
OPEN PRICE () 67.66
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30229
TODAY'S LOW / HIGH ()66.28 67.66
52 WK LOW / HIGH ()63.96 121.12
NSE66.860.3 (+0.45 %)
PREV CLOSE() 66.56
OPEN PRICE () 67.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12523
TODAY'S LOW / HIGH() 66.50 68.49
52 WK LOW / HIGH ()63.86 120.92
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2021

Management Info :

- Chairman Santosh S Vora - Managing Director

Registered Office :

Address : 109, Udyog Kshetra, First Floor,Mulund Goregaon Link Road,Mulund (West),
Mumbai,
Maharashtra-400080

Phone : 022-49712001 / 49717220 / 49717221

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
26Sep Valiant Laboratories informs about scr
With reference to the 4th Annual General Meeting (‘AGM’) of the Company,..
26Jun Valiant Laboratories informs about cre
Valiant Laboratories has informed that India Ratings and Research (Ind-R..
19Feb Valiant Laboratories informs about cre
Valiant Laboratories has informed that CRISIL Ratings have issued the fo..
20Dec Valiant Laboratories informs about vot
In continuation to earlier intimation dated November 19, 2024, informing..
23Aug Valiant Laboratories informs about cre
Valiant Laboratories has informed that CRISIL Ratings have issued the cr..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit1.68-21.4899999999998
Gross Profit 2.59 -14.4699999999998
Operating Profit 9.067.5300000000002
Net Sales 459.881333.62
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1128.80 (6.39%)
M.Cap ( in Cr)
777.96
Amrutanjan Healthcar (BSE)
 689.65 (6.38%)
M.Cap ( in Cr)
1993.82
Lupin (BSE)
 2114.10 (1.62%)
M.Cap ( in Cr)
96571.84
Panacea Biotec (BSE)
 362.70 (9.53%)
M.Cap ( in Cr)
2221.56
Emcure Pharma (BSE)
 1439.60 (2.18%)
M.Cap ( in Cr)
27289.76
Shareholding Pattern
PROMOTERS 74.94%
NON-INSTITUTION 25.04%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85267.66449.53 (0.53%)
NIFTY26046.95148.40 (0.57%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI